Rectal pre-exposure prophylaxis (PrEP)

Antiviral Res. 2013 Dec;100 Suppl(0):S17-24. doi: 10.1016/j.antiviral.2013.09.023. Epub 2013 Nov 1.

Abstract

Rectal pre-exposure prophylaxis (PrEP) will be a critical component of HIV prevention products due to the prevalence of unprotected receptive anal intercourse among men who have sex with men and heterosexual couples. Given the biological considerations of this compartment and the complexity of HIV infection, design of a successful rectal microbicide product faces a number of challenges. Important information is being compiled to begin to address deficits in knowledge toward design of rectal PrEP products for men and women. Aspects of formulation development and preclinical and clinical evaluation of rectal products studied to date are summarized in this review. This article is based on a presentation at the "Product Development Workshop 2013: HIV and Multipurpose Prevention Technologies," held in Arlington, Virginia on February 21-22, 2013. It forms part of a special supplement to Antiviral Research.

Keywords: HIV prevention; Microbicides; Rectal pre-exposure prophylaxis.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Administration, Rectal
  • Anti-Retroviral Agents / administration & dosage*
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • HIV-1 / drug effects*
  • HIV-1 / physiology
  • Homosexuality, Male
  • Humans
  • Male
  • Sexual Behavior

Substances

  • Anti-Retroviral Agents